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CHARACTERIZATION OF SWINEPOX VIRUS SECRETORY POLYPEPTIDES
Takeshi Shimamura, M.S.
Western Michigan University, 1998
Swinepox virus (SPV) is the only known member of the genus Suispoxvirus.
SPV causes a mild disease in swine characterized by slight fever, and weight loss,
associated with lesions restricted to the skin. There have been few studies on SPV.
Other poxviruses, such as vaccinia virus, have been well characterized and the
biological activities of their secretory polypeptides have been analyzed. This study
describes a major SPV secretory polypeptide with an apparent molecular mass of
35kDa.

Poxvirus encoded polypeptides secreted during infection are known to

exhibit immunomodulatory activities. The 35kDa SPV secretory polypeptide was
tested.for its ability to inhibit hIFN-y, hTNF-a, and hIL-1� activities. Results from
these experiments were

inconclusive for SPV polypeptide immunomodulatory

activity on these human cytokines.

Unavailability of swine cytokines restricted

additional studies. Since myxoma virus secretory polypeptide, which is a serine
proteinase inhibitor, is shown to reduce restenosis caused after percutaneous
transluminal coronary angioplasty, SPV polypeptide was tested for similar activities.
SPV secretory polypeptide did not reduce restenosis and lack of evident
immunomodulatory function could explain only mild porcine pathogenesis of SPV.
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INTRODUCTION
Swinepox virus is only known member of the Suispoxvirus genus belonging to
the family Poxviridae. Swinepox virus is a swine pathogen that is endemic in many
swine population. Infections are restricted to porcine species and are relatively mild
and self-limiting (Kasza, Bohl & Jones, 1960). Also, like other poxviruses, SPV
replicates within the cytoplasm of infected cells (Kasza, 1975). However, prior to our
study very little was known regarding the SPV encoded secretory polypeptides.
Poxviruses have evolved multiple polypeptides which are designed
specifically to inhibit the host immune and inflammatory responses (Gooding, 1992).
Many of these poxvirus-encoded anti-immune polypeptides are secreted from
poxvirus-infected cells, and mimic cellular receptors of cytokines or other soluble
immune regulators (Moss, 1996). Cells infected with myxoma virus and Shope
fibroma virus secrete virus-encoded 35kDa polypeptides, that are homologues to the
ligand-binding domain of the cellular receptor for interferon-y (Upton, Opgenorth,
Traktman & McFadden, 1990). Vaccinia virus and Cowpox virus are reported to
encode an IL-1p receptor homologue, which is secreted from infected cells. The IL1p receptor homologue binds and inhibits IL-Ip (Alcami & Smith, 1992; Smith &
Chan, 1991; Spriggs, Hruby, Maliszewski, Pickup, Sims, Buller & Vanslyke, 1992).
It has been demonstrated that Tanapox virus (TPV) encoded 38 kDa polypeptide,
which is an early gene product, binds to hIFN-y, hIL-5, and hlL2 (Essani, Chalasani,
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Eversole, Beuving & Birmingham, 1994).

Lucas et al. (1996) purified serine

proteinase inhibitor (SERP-1), which was a myxoma virus encoded secreted
glycoprotein, to observe effects on plaque growth after balloon angioplasty on
rabbits. Plaque development was reduced by inhibition of serine proteinase activities
and was characterized by decrease in macrophage_ infiltration immediately after the
balloon angioplasty.

This study attempts to identify SPV encoded secretory

polypeptides, which exhibit anti-cytokine activities.
Results presented here, demonstrate that SPV secretory polypeptides do not
bind to human IFN-y, TNF-a, and IL-Ip. Unavailability of swine cytokine prevented
us to further these studies. These results direct to the logical conclusion that SPV
encoded secretory polypeptides are highly species-specific.
Our study demonstrates that systemic SPV infection in swine does not reduce
plaque formation after balloon angioplasty on the swine coronary artery. Endemic
nature of SPV in swine population and a lack of established methods for measuring
anti-SPV antibody titer in serum samples from swine are major problems. To
elucidate true effects of SPV encoded secretory polypeptides on atherosclerotic
plaque formation, either obtaining SPY-free swine population or purifying SPV
encoded secretory polypeptides are required.

REVIEW OF LITERATURE
General Characteristics of Swinepox Virus
Swinepox virus (SPV) is classified in the genus Suispoxvirus of the family
Poxviridae. SPV is a large enveloped DNA virus and appears oval or brick shape
(Moss 1996). The non-infectious SPV genome is a 175 k bp linear double stranded
DNA (Massung & Moyer, 1991). The DNA of SPV is terminally cross-linked and
contains terminal inverted repetitions (TIRs) similar to the genere Orthopoxvirus and
Leporipoxvirus (Massung & Moyer, 1991). Structural components of SPV include a
core, lateral bodies, surface protein, and membranes; these are all common
Poxviridae properties. Also, like other poxviruses, SPV replicates within the
cytoplasm of infected cells (Kasza, 1975) and produce a cytopathic effect (CPE) with
characteristic intracytoplasmic inclusions and vacuoles in the cytoplasm (Kasza,
1975).
Historical Background
The earliest reports of Swinepox are found in the early European literature.
Spinola (1842), Bollinger (1877), Peiper (1901), and Szanto (1906) described
swinepox and associated it with vaccinia virus (VV). Swinepox was first described in
North America in 1929 (McNutt, Murray & Purwin, 1929). In 1940, it was reported
that both VV and SPV caused swinepox, and that SPV was swine specific
3
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(Manninger, Csontos & Salyi, 1940). A further study was conducted to ensure
that the pox in swine was caused by either SPV or VV (Schwarte & Biester,
1941 ). In 1960, SPV was isolated and cultivated from swine tissue cultures.
Epidemiology
Swine can be infected with both SPV and VV under both experimental
and natural conditions, and the natural infection is maintained in the herd
indefinitely due to the method of raising pigs and the characteristics of
poxviruses. Since new stock continuously replace adult pigs, these young animal
provide a susceptible host for continuous infection. However little attention has
been paid for elimination of SPV due to the low rate of pig mortality. Also
infected swine are a constant source of SPV because resistance of the poxvirus in
dried crusts contribute to a continuous herd infection (Kasza, 1975). Unless
effective viricidal agents are used, SPV can survive for at least 1 year in dried
form (Kasza, 1975).
Transmission of SPV is by direct contact. Thus, there is no evidence for
transmission by other infection routes. Skin injury is necessary for infection.
Normally, SPV is transferred from one pig to another pig by lice which cause skin
injury and generate and SPV portal of entry. Other blood-sucking insect vectors
may also play a similar role in transmission of SPV. Younger pigs in a herd are
more susceptible to infection, because older pigs may acquire immunity from a
previous SPV infection.
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Clinical Signs, Gross Lesions, and Pathogenesis
The incubation period of SPV infection is 3 to 6 days and the course of
infection is 1.5 to 3.5 weeks (Kasza, 1975).

SPV infected pigs under

experimental conditions show a slight elevation of body temperature 2 to 4 days
post-inoculation (Kasza, 1975). Swine consume le.ss food than usual during the
temperature elevation (Kasza, 1975). After 7 days post-infection, small red skin
lesions become visible and further develop into papules which are abundant on
the face, ears, inside the legs, and on the abdomen. The papules further develop
into pustules within a few days.

Pustle centers tum dry, are scabbed, and

surrounded by an inflamed area that appear umbilicated. Most of the dried crusts
are scrubbed off twenty-one days post-infection and only small, white, and
discolored spots are visible (Kasza, 1975). The only organs, besides the skin, that
develop macroscopic lesions are inguinal lymph nodes (Kasza, 1975).
Microscopic Lesions
The earliest microscopic changes are detectable three days post-infection.
Hydropic degeneration in the stratum spinosum causes the epidermis to focally
thicken. Vacuoles in the nuclei are observed in a few cells. This papular stage
progresses and the epidermis increases in thickness due to hydropic degeneration
and epithelial hyperplasia. At this stage, cytoplasmic inclusions and nuclear
vacuoles are evident. Infiltration of dermis with immune cells and dilatation of
blood vessels are observed. Subsequent small vesicles are visible in the epidermis
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due to cell rupture and convergence. In the pustular stage, extensive necrosis is
detected in the basilar layer which is often characterized by infiltration of
neutrophiles and a lesser number of eosinophiles and lymphocytes. At this stage,
small vesicles are still visible in the stratum spinosum. Vacuoles in the nuclei and
cytoplasmic inclusions are present at the border of the necrotic area. When dried
crusts are formed, both cellular necrosis and crust formation are the most
abundant feature of the lesion. At the same time, epidermis regeneration is in
progress. Electron microscopic examination revealed that viral replication in the
skin of experimentally inoculated pigs is limited to the cytoplasm of epidermal
cells (Kasza, 1975).
Kinetics of SPV Infection
SPV is characterized by slow growth in tissue culture (Kasza, 1975). CPE
is not evident until approximately four days post-infection when Porcine Kidney
Cells (PK-15 cells) are infected with SPV (Massung & Moyer, 1991a).

In

contrast, CPE is evident prior to 24 hours post-infection with Orthopoxviruses
such as vaccinia virus (Moss, 1996). Pulse labeling of infected PK-15 cells and
Coomassie-stained total protein patterns fail to detect expression of SPV viral
proteins prior to 24 hours post-infection (Massung & Moyer, 1991b). By 32
hours post-infection, however, SPV viral proteins are clearly detected and their
production continues to increase through 48 hours (Massung & Moyer, 1991b).
On the other hand, using immunoprecipitation technique, early viral protein
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synthesis is detected by 4 hours post-infection and late viral proteins are evident
as early as 12 hours post-infection (Massung & Moyer, 1991b). It has been
reported (Massung & Moyer, 1991b) that the pattern of viral protein synthesis
prior to 32 hours post-infection is disguised because SPV ineffectively shuts off
host protein synthesis prior to 24-32 hours post-infection. Massung et al. (1991a)
designed an experiment to measure the accumulation of replicated viral DNA.
The result revealed that DNA accumulation differs significantly between SPV and
vaccinia over 48 hours post-infection. The accumulation of replicated SPV DNA
is first detectable at 12 hours post-infection and does not peak until 48 hours
(Massung & Moyer, 1991a). On the other hand, the accumulation of replicated
vaccinia DNA is detectable at 6 hours post-infection and peaks at 24 hours post
infection.

Messenger RNA (mRNA) transcription analysis of SPV also

corresponds with DNA analysis and exhibit reduced mRNA synthesis compared
to mRNA synthesis in vaccinia virus. Kinetics of DNA, mRNA, and protein
synthesis directed by SPV reveals that SPV is unusual among well-characterized
mammalian poxviruses. Tanapox virus is also a slow growing virus and CPE is
not evident in TPV infected tissue culture cells until 3 to 4 days post-infection
(Knight, Novembre, Brown, Goldsmith, & Esposito, 1989).
Viral Genome
Poxviruses are large, double-stranded DNA viruses which develop in the
host cell cytoplasm. Poxvirus genomes are approximately 130 to 280 kbp and all
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poxvirus isolate characterized have covalently cross-linked termini. The results of
pulsed-field electrophoresis analysis reveal the SPV genome to be 175 kbp with
4,300 bp TIRs (Massung, Jayarama & Moyer, 1993). Complete DNA sequence
analysis of the Copenhagen strain of vaccinia virus revealed a conserved,
common pattern of genomic organization composed of a conserved central core
and variable near terminal regions (Goebbel, Johnson, Perkus, Davis, Winslow &
Paoletti, 1990). According to the analysis, the core region of the vaccinia virus
DNA encodes the enzymatic and structural components necessary for the viral
cytoplasmic life cycle and the near terminal regions of the poxvirus DNA encode
products necessary for the wide range of pathogenic effects and host specificity.
Inspired by this finding, Massung et al. (1993) examined the nucleotide sequence
of fragments from several regions of the SPV genome including a 2.85 kb
fragment from the potentially conserved part and two fragments, 14.2 kb and 3.6
kb, within the presumed variable near-terminal regions which tend to be unique
for a given poxvirus. These latter fragments were found to encode 25 open
reading frames (ORFs) including proteins predicted to be secreted or membrane
bound in SPV infected cells. A few unique SPV ORFs which might be involved
in immune modulation, cell attachment and pathogenesis were detected
(Massung, Jayarama & Moyer, 1993). Comparison of amino acid sequences
between SPV and vaccinia revealed that a few polypeptides encoded within the
near terminal regions of the vaccinia virus DNA, which determine virulence and
host range, were lacking within the same region in SPV. Functional homologues
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of vaccinia growth factor, complement binding protein, and ORFs responsible for
determining host range were not found in near terminal regions of SPV.
Virus Entry
There are many conflicting theories explaining poxviruses entry into cells
(Moss, 1996). This controversy is due to the existence of infectious intracellular
matured virions (IMV) and infectious extracellular enveloped virions (EEV)
(Moss, 1996). It is not yet known if there is a cell surface receptor for viral
attachment. Electron microscopic examination reveals that vaccinia IMV is fused
to membranes by pinocytosis (Dales & Kajioka, 1964) and to the plasma
membranes (Chang & Mets, 1976). A study with lysomotoropic agents suggests
that the plasma membrane is a fusion site (Moss, 1996). Another study fusion
(Doms, Blumenthal & Moss, 1990) using a fluorescent assay revealed that a
neutral pH and temperature-dependent process is required for vaccinia IMV cell.
Using antibody neutralization studies, several vaccinia membrane proteins have
been shown to be important in cell surface attachment and/or penetration (Oie &
Ichihashi, 1981). Several vaccinia gene products bind with high affinity to the
surfaces of a variety of cells (Lai, Gong & Esteban, 1990). Although recent
studies (Moss, 1996) indicate that a vaccinia virus-encoded protein, vaccinia
growth factor (VGF), has the ability to bind to the cellular epidermal growth
factor (EGF) receptor, the general importance of the EGF receptor for vaccinia
virus entry is not conclusive.
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Neutral pH is known to be required for EEV fusion to cell surface (Moss,
1996). The mechanisms of entry of EEV into host cells have not been elucidated.
It has been suggested (Moss, 1996) that the entry mechanisms of EEV differ from
that of IMV since EEV infectivity is not neutralized by antibody to IMV.
Viral Polypeptides
Poxvirus contains large variety of polypeptides. Approximately 30 bands
are clearly resolved

by sodium dodecyl sulfate polyacrylamide gel

electrophoresis (SDS-PAGE) of vaccinia virus purified from infected cells and
disrupted with sodium dodecyl sulfate and reducing agent (Moss, 1996). Also,
even more polypeptides are detected with two-dimensional gel electrophoresis.
Little is known about the polypeptides produced upon SPV infection.
Immunoprecipitation and immunoblot revealed that at least 8 major polypeptides
(97kD, 65kD, 48kD, 35kD, 32kD, 18kD, 15kD, and 12kD) are present (Ouchi,
Fujiwara, Hatano, Yamada & Nii, 1992). Neither structural nor secretory proteins
due to SPV infection have not been characterized at all.
Although characterization of isolated SPV secretory proteins has not been
done, DNA sequence studies have revealed putative properties of some SPV
secretory proteins. The near terminal regions of SPV DNA (Massung, Jayarama
& Moyer, 1993) may encode membrane-bound or secreted viroceptors that bind
to various immune components (based on the presence of foreseen hydrophobic
leaders and internal transmembrane domains). DNA analysis revealed that three
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SPV open reading frames (ORFs) encode polypeptides that are homologues to a
serine proteinase inhibitor (serpin), an interferon gamma receptor, and a G
protein-coupled receptor (Massung, Jayarama & Moyer, 1993). The SPV KlR
ORF showed high degree of homology (32.1% identity in 343 amino acid) of the
cowpox virus 38 k:Da protein, a serpin homologue which is shown to inhibit the
cellular interleukin 1 � converting enzyme (Upton, 1992; Massung, Jayarama &
Moyer, 1993). The SPV ORF C6L is homologous to the human interferon-y
receptor (Massung, Jayarama, & Moyer, 1993). The SPV ORF C6L is also
homologous to myxoma virus and Shope fibroma virus interferon-y receptor
homologues (Upton, 1992; Massung, Jayarama & Moyer, 1993). These DNA
base sequence studies also revealed the SPV ORFs C3L and K2R to be members
of the G-protein coupled receptor family (Massung, Jayarama & Moyer, 1993).
Virus Host Interactions
Inhibition of Host Macromolecular Synthesis
Utilization of host biosynthetic processor is a requirement for all viruses.
Therefore, poxviruses are believed to inhibit host DNA, RNA, and protein
synthesis upon infection. Infection of tissue culture cells with orthopoxviruses
shows cytopathic effects, changes in membrane permeability, and inhibition of
DNA, RNA, and protein synthesis (Moss, 1996). Several factors may be involved
for the switch from host to viral protein synthesis. The comparative contribution
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of each factor may rely on the virus multiplicity, cell type, time of analysis, and
use of metabolic inhibitors (Moss, 1996). The surface tubules, the BIR protein
kinase, and the F17R phosphoprotein in vaccinia virus particles inhibit host
protein synthesis in the absence of viral gene expression (Mbuy, Morris & Bubel,
1982; Beaud, Sharif, Topamass & Leader, 1994; Person-Fernandez & Beaud,
1986). Also, small poly (A)-containing RNA molecules may play an inhibitory
role during viral infection (Cacoullos & Bablanian, 1991).

Synthesis and

processing of host cell RNAs are also inhibited on initiation of vaccinia virus
protein synthesis (Moss, 1996).
Stimulatory Effects on Cell Growth

It is common for poxviruses to exhibit hyperplasia and tumors in the host
skin. These consequences of poxvirus infection are well documented in fowlpox
virus, Shope fibroma virus, Yaba virus, and molluscum contagiosum infections
(Moss, 1996).

Secretion of poxivirus encoded growth factors is believed to

contribute to hyperplasia. Vaccinia virus growth factor (V GF) also shows
homology to epidermal growth factor (EGF) and transforming growth factor
a (Blomquist, Hunt & Barker, 1984). The secreted VGF can bind to the EGF
receptor of hosts and stimulate cell growth. Although these effects of VGF are
not observed in tissue culture cells, a rapid proliferation of ectodermal and
endodermal cells of the chicken embryo chorioallantoic membrane does occur
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(Moss, 1996). Vaccinia virus lacking VGF has diminished virus replication in
vivo and an attenuated pathogenecity (Moss, 1996).
Viral Defense Molecules
Vertebrates have developed a highly sophisticated immune system to
suppress virus propagation.

Soon after introduction of virus, non-specific

immune factors such as complement, interferons, and natural killer cells suppress
virus invasion. Cytotoxic T cells and virus specific antibodies neutralize and
inactivate viruses. Some viral (virulence factor) proteins secreted from poxvirus
infected cells have the ability to inhibit host immune responses (Barinaga, 1992).
Immune evasion properties are known for a wide spectrum of viruses. Those
include herpes simplex virus type 1, adenoviruses, and retroviruses such as HIV
(Gooding, 1992). The concept of virokine or viroceptor has been introduced for
viral proteins responsible for immune evasion (Gooding, 1992).
Viral Protein - SERPIN Superfamily
Host cell cytokines IL-1a and IL-1 � are responsible for inhibiting early
stages of viral infections and to regulate the host inflammatory process. Several
poxviruses have developed strategies to inhibit actions of IL-1. The cowpox virus
gene responsible for encoding immune evasive protein has sequence motifs
common to the serine proteinase inhibitor (SERPIN) superfamily (Palumbo,
Pickup, Frederickson, McIntyre & Buller, 1989). In vitro studies have revealed
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that this gene product, SPI-2 or crmA, inhibits the IL-1p converting enzyme
which is an atypical cysteine proteinase (Ray, Black, Kronheim, Greenstreet,
Sleath, Salvesen & Pickup, 1992). By inhibiting intracellular conversion of the
precursor of IL-1p to the active form, crmA can function as a viral anti
inflammatory molecule. Cells infected with myxoma virus secrete SERP-1 (a
related but distinct SERPIN homolog), since a deletion mutant of myxoma virus
lacking the SERP-1 gene results in a significant attenuation of the virus, it is
possible that SERP-1 interferes with inflammation (Macen, Upton, Nation, &
McFadden, 1993). SERP-1 is also known to inhibit, in vitro, a number of serine
proteinases such as plasmin, urokinase, tissue plasminogen activator, and a
constituent of the complement component cascade (Macen, Upton, Nation &
McFadden, 1993).
IL-1 and TNF Receptor Homologues
Vaccinia virus and Cowpox virus encode an IL-1p receptor homologue
which is secreted from infected cells and the IL-1p receptor homologue binds and
inhibits IL- lp (Alcami & Smith, 1992; Smith & Chan, 1991; Spriggs, Hruby,
Maliszewski, Pickup, Sims, Buller & Vanslyke, 1992). Schreiber et al. (1994)
have identified a myxoma virus tumor necrosis factor (TNF) -receptor homologue
(T2), which inhibits TNF a. Tanapox virus also secretes a soluble TNF receptor
homologue which binds to human TNF a (Paulose and Essani, unpublished data).
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Inhibitors of Interferon
Type I and type II interferons play a major role in host defenses against
poxviruses (Karupiah, Frederickson, Holmes, Khairallah & Buller, 1993). Two
examples of interferon regulation have been well identified. First, the double
stranded RNA

dependent protein

kinase

(PKR) pathway directs the

phosphorylation of the eukaryotic translation initiation factor eIF-2a which
results in inhibition of protein synthesis (Moss, 1996). Second, vaccinia virus
encoded A18R protein, which is a DNA dependent ATPase, enhances degradation
of mRNA and rRNA which is interceded through the 2-5A/Rnase L pathway as a
result of abnormal transcription (Bayliss & Condit, 1993). Poxviruses also utilize
secretory proteins to protect themselves against interferons. Cells infected with
myxoma virus and Shope fibroma virus secrete virus-encoded 35 kd proteins that
are homologus to the ligand-binding domain of the cellular receptor for interferon
y (Upton, Opgenorth, Traktman & McFadden, 1992). These proteins selectively
bind and inhibit interferon y. Vaccinia and variola viruses are also known to
encode secretory proteins that are interferon y receptor homologues (Massung,
Esposito, Liu, Qi, Utterback & Knight, 1993; Moss, 1996).
Complement Regulatory Protein
Complement components are capable of enhancing antibody mediated
neutralization of viruses.

Several poxviruses have developed means of
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modulating classical and alternative pathways of complement activation. The
major secretory protein of vaccinia virus, VCP, binds the C4b fragment of
complement component C4 and thus inhibits complement fixation directed by the
classic compliment pathway (Kotwal, Issacs, McKenzie, Frank & Moss, 1990).
The protein also inhibits the alternative pathway of complement fixation (Moss,
1996).
Cell Adhesion Molecules
The molecular basis of cellular adhesion in vertebrates is regulated by cell
adhesion molecules (CAMs).

Intercellular adhesion molecules (ICAMs) are

expressed on activated endothelial cells, where they bind to integrins on the
surface of white blood cells and aid in adherence of these blood cells at sites of
inflammation (Edelman & Crossin, 1991).

ICAM-1 also binds lymphocyte

function associated protein 1 (LFA-1) on stimulated T cells.
The majority of T and B cells continuously recirculate between the
cardiovascular system and the lymphatic system. In a lymph node, lymphocytes
migrate from the blood stream to small lymphatic vessels. This event depends on
specific interactions between the lymphocyte surface and the surface of
specialized endothelial cells lining small veins in a lymph node. Many cell types
in the cardiovascular system interact with these endothelial cells, but only
lymphocytes adhere and migrate out from the blood stream to the lymphatic
vessels.

This migration is supported by varieties of homing receptors on
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lymphocytes and by the ligands for these receptors on endothelial cells. A cell
adhesion protein called E-Selectin supports migration of lymphocytes from the
blood stream to lymphatic vessels. This homing receptor, which is present on
most lymphocytes, binds specific ligands on the endothelial cells lining venules in
lymph nodes. E-selectin binding causes the lymphocyte to attach weakly to the
endothelial cells and to roll slowly on the surface. Rolling continues until a
stronger adhesion mechanism is applied. A member of integrin family of CAMs
on the lymphocyte surface mediates strong adhesion. Upon strong adhesion, the
lymphocyte stops rolling and penetrates through the blood vessel out to the
lymphatic vessels. When inflammation occurs and T and B cells are activated
with antigens and most of lymphocytes lose their original homing receptors and
express special receptors to migrate to injury sites. The migration of activated
lymphocytes and other white blood cells is mainly interceded by other selectins
and integrin families.
Based on the fact that CAMs are important mediators of the inflammatory
response, they are often a target for inhibition.

For example, P-selectin is

expressed on activated platelets and endothelium and mediates neutrophil binding
to both cell types. Neutrophil infiltration at lesions on balloon angioplasty injured
site is a major mediator in post-percutaneous transluminal coronary angioplasty
restenosis. Substances which are capable of inhibiting P-selectin interactions may
be able to reduce restenosis.
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Restenosis and Percutaneous Transluminal Coronary Angioplasty
Percutaneous transluminal coronary angioplasty (PTCA) is a common
procedure for providing relief of angina pectoris in patients with single and
multivessel coronary artery disease. Angiographic renarrowing at the site of a
previous PTCA is known as restenosis and occurs in approximately 40% of
patients at 6 months (Lucas, Liu, Macen, Nash, Dai, Stewart, Graham, Etches,
Boshkov, Nation, Bumen, Hohman & McFadden, 1996). Although the typical
restenotic lesion is different from the atherosclerotic plaque in architecture and
composition, both restenotic and atherosclerotic plaques contain smooth muscle
cells and fibrous tissue. Restenosis after PTCA is the major problem limiting the
long-term efficacy of PTCA.

A critical step in restenosis is thought to be

activation of inflammatory response, including platelet adhesion, platelet
aggregation, fibrin deposition, and leukocyte infiltration (Hermans, Rensing,
Bradley, Strauss & Serruys, 1991). Activation of the inflammatory response is
followed by intimal smooth muscle cell proliferation and migration, which is
initiated by both cellular components of the blood and damaged vascular
endothelial cells (Liu, Roubin & King, 1989). Anticoagulants, antiplatelet agents,
antiproliferative agents, calcium channel blockers, lipid-lowering agents, and
inflammation inhibitors have all been unsuccessful in prevention of restenosis
(Hermans, Rensing, Bradley, Strauss & Serruys, 1991).
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Clinical Significance of Viral Polypeptides in Restenosis
The search for a so-called magic bullet, which prevents restenosis after
PICA, is on intense area of biological research. After the vascular injury caused
by PICA, inflammatory responses are major contributors to restenosis.

The

inflammatory responses involve many inflammatory enzymes and thrombotic
enzyme cascades, which have serine proteinase activity and are regulated by
serine proteinase inhibitors (Altieri, 1995). Coagulation and fibrinolytic enzymes
are known to induce monocyte motility and chemotaxis, tissue infiltration,
cytokine responses, cell proliferation, and apoptosis (Lucas, Liu, Macen, Nash,
Dai, Stewart, Graham, Etches, Boshkov, Nation, Bumen, Hohman & McFadden,
1996). One of serine proteinase inhibitor, plasminogen inhibitor- I (PAI-1), has
been demonstrated to play a significant role in suppression of intimal hyperplasia.
Transgenic mice that lack PAI-1 gene showed accelerated intimal hyperplasia as
histologically (Carmeliet, 1995; Carmeliet, Seboojans, Kieckans, Ream, Degan,
Bronson, DeVos, van den Oord, Collen & Mulligan, 1994). Likewise, inhibition
of plasminogen with traexamic acid reduced smooth muscle cell migration in rats
following arterial balloon injury (Jackson & Reidy, 1992). Lucas et al. (1996)
obtained the purified serine proteinase inhibitor, (SERP-1), which was a myxoma
virus encoded secreted glycoprotein, to observe effects on plaque growth after
balloon angioplasty on rabbits when it is administered locally. Plaque
development was reduced by inhibition of serine proteinase activities and was
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characterized by a focal decrease in macrophage infiltration immediately after the
balloon angioplasty.
Antiviral Therapy in the Treatment of Restenosis After Angioplasty
Coronary restenotic lesions have common_ features with benign tumors
such as increased presence of proliferating vascular smooth muscle cells
(McEwan, 1995). 50% of human benign tumors involve mutation of the p53
gene, which has a tumor suppressive activity. Spier et al. (1994) focused on
effects of human Cytomegalovirus (HCMV) infection on atherosclerotic
proliferation of vascular smooth muscle cells. HCMV is known for producing a
protein, IE84, which elicits a repressor effect on p53 expression. Spier et al.
(1994) found that vascular injury induced reactivation of HCMV infection at the
angioplasty injured site which resulted in IE84 expression.

Enhanced IE84

expression inhibited degradation and the repressor effect of p53 in the vascular
smooth muscle cells. Therefore, the inhibition of p53 gene activity resulted in the
proliferation of vascular smooth muscle cells, which is a common feature of the
post-angioplasty restenosis. Though this finding had a great impact in restenosis
research, it is still inconclusive. In addition, scientists who believe that restenosis
is caused by viral infection investigated this further.

Ohno et al. (1994)

introduced the concept of applying antiviral therapy to the prevention of
restenosis. The antiviral agent, gancyclovir, was locally injected to pigs after
balloon catheter induced iliac artery mJury.

At the same time, a replication
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deficient adenovirus, which possessed the viral enzyme thymidine kinase, was
transfected in the injured vessels. The enzyme is known to transform gancyclovir
to a cytotoxic metabolite that selectively kills actively proliferating cells. This
experiment resulted in substantial inhibition on neointimal formation.

MATERIALS AND METHODS
Virus and Cell Lines
SPV was obtained from American Type Culture Collection, Rockville,
Maryland, and cultivated in monolayers of Porcine Kidney 15 (PK-15) cells. PK-15
cells were grown in RPMI 1640 (Gibco Laboratories, Grand Island, NY) containing
10 % (v/v) newborn calf serum (NBCS), 200mM glutamine and antibiotics (100
units/ml penicillin G sodium, 100 µg/ml streptomycin sulfate, and 0.25µg/ml
amphotericin B) (Growth Medium). Cells were cultured at 37° C in an incubator with
5% CO2. Unless noted, cells were infected with 1~2 plaque forming unit (pfu) per
cell followed by adsorption on a rocking platform at room temperature for one hour.
Following the adsorption, infected cells were maintained in RPMI 1640 containing
2% (v/v) NBCS, 200mM glutamine, and antibiotics (Maintenance medium) at 37° C
with 5% CO2.
Expanded surface 1700 cm2 plastic roller bottles (Coming, Rochester, NY)
were also used with Earle's minimum essential medium (EMEM) containing 2%
(v/v) NBCS, 200mM glutamine, and antibiotics to prepare bulk virus. Infected cells
were harvested 7-8 days post-infection using a rubber policeman and cells were
pelleted by centrifugation at 1500 xg (IEC PR-6000 refrigerated superspeed
centrifuge) for 20 minutes. The pellet was resuspended in serum free RPMI 1640
with antibiotics. In order to release intracellular viral particles, three cycles of freeze22
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thawing was carried out. Then nuclei and large cytoplasmic debris were removed by
centrifugation at 1500 xg (IEC PR-6000 refrigerated superspeed centrifuge at 2000
rpm) for 15 minutes. Supematants were then centrifuged at 85,000 xg (Beckman L870M ultracentrifuge; Ti-70.I fixed angle rotor) for 30 minutes to pellet SPV. The SPV
pellet was resuspended in RPMI 1640 containing 2% (v/v) NBCS, 200mM glutamine,
and antibiotics to a final concentration of 100X. The concentrated SPV was stored at
-20 °C.
Titration of SPV
SPV was quantitated by serial dilution method. Monolayers of PK-15 cells in
6 well dishes were infected with 10-4, 10-5, and 10-6 dilution of 100X SPV followed
by adsorption on a rocking platform at room temperature for one hour.

Then

monolayers were washed with serum-free RPMI 1640 with 200mM glutamine, and
antibiotics three times.

Monolayers were then incubated with overlay medium

(maintenance medium containing 1 % (w/v) carboxymethylcellulose) for 14 days at
37°C with 5% CO2. After incubation, infected monolayers were fixed and stained
with 1% crystal violet in 10% formaldehyde to visualize plaques. 100X virus was
titrated to be 3.25 X 10 8 pfu/cell on average.
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Identification of SPV Secretory Proteins
Metabolic Labeling Studies of SPV Infected Cells
Fresh monolayers of PK-15 cells were grownin 60 mm dishes. Cells were
infected with SPV at multiplicity of infection of_ l O or 20 pfu/cell. After 1 hour
adsorption at room temperature, maintenance medium was added to the dishes and
incubated for 6 hours at 37°C with 5% CO2. Then the supematants were removed
and monolayers were washed twice with serum-free RPMI 1640 with antibiotics,
after which 2ml of methionine-free EMEM (Gibco Laboratories, Gland Island, NY)
without serum was added to each dish. Dishes were then incubated at 37 °C with 5%
CO2 for one hour. Following incubation, supematants were removed and 2ml of
methionine-free, serum-free EMEM supplemented with 100 µCi [S35 ]methionine/ml
at 1504Ci/mmol (ICN,Costa Mesa, CA) was added to monolayers. The supernatant
was collected 10 to 18 hours later, depending on experiments.

Cells in the

supematants were removed by centrifugation at 1500 xg (IEC PR-6000 refrigerated
superspeed centrifuge) for 20 minutes followed by ultra-centrifugation at 85,000 xg
(Beckman L8-70M ultracentrifuge; Ti-70.I fixed angle rotor) for 30 minutes to pellet
cell debris and SPV. In order to recover SPV secretory polypeptides, the supematants
were then concentrated 5-fold by centrifugation in a Microcon 3 concentrator
(Amicon, Beverly, MA) or in a Centriprep 3 concentrator (Amicon, Beverly, MA) for
larger quantities. In an attempt to collect intracellular SPV proteins, monolayers were
scraped off with a rubber policeman at the time of harvesting and centrifuged at 1500
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xg (IEC PR-6000 refrigerated superspeed centrifuge) for 20 minutes. Then medium
was decanted and NP-40 (BRL - Shell Oil Company, Rockville, MD) was added to
the remaining pellet to avoid DNA contamination.

Protein samples from

concentrated supematants were mixed with an equal volume of a protein loading
solution and solubilized by boiling for 3 minutes_. The solubilized proteins were
resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
using a 10.5% gel. Radiolabeled proteins were visualized by autoradiography of the
dried gel. The dried gel was exposed to Kodak X-Omat AR film (Eastman Kodak,
Rochester, NY) for a minimum of 48 hours.

Where indicated, prior to

autoradiography, presence of SPV secretory proteins were visualized with silver
staining by using Bio-Rad Silver Stain Kit (Bio-Rad Laboratories, Richmond, CA) or
Commasi blue staining. Low molecular marker (Bio-Rad Laboratories, Hercules,
CA) was used to estimate molecular weights of proteins.

All autoradiograms

presented were scanned on a Microtek Laboratories Scanmaker E6PRO and
organized with Adobe Photoshop 4.0. Autoradiograms were then printed on a 600
dpi x 600 dpi NEC Super Script 860 Laser Printer.
Early and Late Protein Experiment
Upon poxv1rus infection, two maJor types of proteins are known to be
produced. One is the early protein, which is a poxvirus gene product produced before
poxvirus successfully shuts down host protein synthesis. The other is the late protein,
which is a poxvirus gene product produced after the termination of host protein
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synthesis.

Protein labeling was conducted as described above.

Cytosine

P-D

Arobinofuranoside (AraC) (Sigma, St.Louis, MO), which blocks late but not early
viral protein synthesis, was added to one of the samples (12.5 µI/ml) in addition to
[S35 ]methionine (100 µCi) so that only early proteins were detectable in samples.
Amount of Ara C used in this experiment was chosen by results from a previous
publication (Sharad & Boyle, 1990).
Pulse-Chase Experiment
A pulse-chase experiment was performed to exhibit kinetics of SPV protein
expression. SPV secretory proteins and SPV polypeptides inside cells were chased for
20 hours postinfection (9 hours after radiolabeling) and pulsed for 11 hours
postinfection (1 hour after radiolabeling) with 100 µCi [S35 ]methionine/ml at
1504Ci/mmol (ICN, Costa Mesa, CA). Both supernatant and pellets were recovered
and processed as described above.
Characterization of SPV Secretory Polypeptides
Interferon Gamma Assay
The biological activity of human IFN-y (hIFN-y) was assayed by its ability to
inhibit coca) virus plaque formation. The protocol was basically duplicated from a
previous publication was followed (Essani, Chalasani, Eversole, Beuving &
Birmingham, 1994).

hlFN-y was assayed in cultures of PK-15 cells. Although,
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human cells should be used due to the species specificity of the IFN-y, PK-15 cells
had to be used due to the fact that SPV only infects porcine cells. Cell monolayers in
6 well dishes (Gibco, Grand Island, NY) were pretreated with 2% RPMI 1640
containing 2% NBCS with antibiotics and indicated doses of IFN-y and concentrated
supematants from SPV infected cultures. After a 1.0 hr incubation at 37 °C with 5%
CO2, the cells were infected with 100 pfu/cell of SPV and incubated for a further 9 to
14 days at 37 °C with 5% CO2 in media containing 1 % (w/v) carboxymethylcellulose.
After incubation, the supematants were removed and monolayers were stained with
crystal violet dye to count plaques. It has to be noted that virus-free supematants
from the infected cultures did not form plaques in the absence of SPV.
Human Recombinant Tumor Necrosis Factor Alpha
and Human Recombinant Interleukin- Ip Assay
Cell Culture
Human umbilical vem endothelial cells (HUVEC) were obtained from
Clonetics (San Diego, CA).

Cells were plated in a 75 cm2 tissue culture flask

(Coming, Indianapolis, IN) pretreated with 1% gelatin (Difeo, Detroit, Ml). Growth
medium consisted of 10 ng/ml human recombinant epidermal growth factor, 1 µg/ml
hydrocortisone, 2% fetal bovine calf serum (Clonetics, San Diego, CA), 50 µg/ml
gentamicin, 50 ng/ml Amphotericin-B, 12 µg/ml bovine brain extract, and 10 µg/ml
heparin. HUVEC were grown as monolayers in 96 well microtiter plates (Coming,
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Rochester, NY) pretreated with 1% gelatin. The microtiter plates were incubated at
37 °C with 5% CO2, with daily changes of growth medium until confluent.
Treatment of HUVEC With Recombinant Human TNF a and SPV Protein Samples
or Human Recombinant Interleukin-Ip and SPV Protein Samples
Concentrated 5x supematants from either SPY-infected or mock-infected cells
were prepared as described above.

Mixtures of indicated doses of recombinant

human TNF-a (Genzyme, Cambridge, MA) or recombinant human IL-I� (R&D
Systems, Minneapolis, MN) and the concentrated supematants were introduced to the
confluent HUVEC cells on microtiter plates. Microtiter plates were then incubated at
37 °C for four hours. After incubation, the microtiter plates were washed with 1x PBS
and fixed with 1% paraformaldehyde in PBS and stored at 4 ° C for 10 to 15 minutes.
After fixation, the microtiter plates were washed with PBS and blocked with 2%
bovine serum albumin (BSA) in PBS supplemented with NaN3 (0.02 g/dl). The
microtiter plates were incubated at 37 °C for at least one hour. After removal of the
blocking solution, the microtiter plates were washed with PBS and stained with
primary antibody (1 µg/ml in PBS, 0.1 % BSA). Primary antibodies were mouse
anti-ICAM-2 monoclonal antibody (Biosource International, Camarillo, CA), mouse
anti-ICAM-1 monoclonal antibody (R & D Systems, Minneapolis, MN), mouse anti
VCAM-1 monoclonal antibody antibody (R & D Systems, Minneapolis, MN), mouse
anti-E-Selectin monoclonal antibody (R & D Systems, Minneapolis, MN). After the
addition of primary antibodies, the microtiter plates were incubated at 37 °C for two
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hours. Microtitier plates were rewashed with PBS containing 0.05% Tween 20
followed by a single wash with PBS.

After the wash, 100 µ1/ well alkaline

phosphatase-conjugated goat anti-mouse lgG (1 µ g/ml in PBS, 0.1% BSA) was added
and incubated further at 3 7 °C for two hours. The microtiter plates were washed with
PBS containing 0.05% Tween 20 with PBS. Chromogenic substrate, p-nitrophenyl
phosphate (1 mg/ml in PBS), was added and incubated at room temperature for 10 to
20 minutes depending upon the degree of reactions. Microtiter plates were read in a
fluorescence microtiter plate reader at an optical density of 405 nm. Results were
recorded with the aid of computer software.
Atherosclerosis Study
Pigs and Diet
Female and male domestic feeder pigs (Yorkshire-Hampshier-Landrace
Duroc crosses, 2-3 months old) were provided from Pharmacia & Upjohn Farms and
fed on S-985 chow (18% crude protein, Pharmacia & Upjohn feed) until the
percutaneous transluminal coronary angioplasty (PTCA) procedure. After PTCA, the
animals were fed S-810-L chow (16% crude protein, including 200 gm/ton of the
antibiotic lincomycin; Pharmacia & Upjohn feed) throughout the rest of the study.
SPY Production and Infection Procedures
A I 00X SPY preparation was prepared as described above. The I 00X virus
was diluted to a final concentration of I x 108 pfu/ml RPMI 1640. Pigs selected for
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this study were infected one week prior to a PTCA balloon over-inflation procedure.
A 20 ml venous blood samples was also taken by a superior vena cava venipuncture.
Blood samples were incubated in a 37 °C water bath in order to separate sera. These
blood samples were used as control serum samples and stored at 4°C until analysis.
Pigs were subsequently injected subcutaneously in the right inguinal fold with either
live SPV (1 x 108 pfu/ml RPMI 1640) or 1ml ofRPMI 1640 vehicle of conscious pigs
in separated rooms.
Percutaneous Transluminal Coronary Angioplasty (PTCA)
The procedure used to intentionally over-stretch a 2 cm segment of porcine
left anterior descending (LAD) coronary artery has been described in detail
(Humphrey, Simmons, Toombs & Shebuski, 1994).

PTCA was performed on

ketamine/midazolam anesthetized pigs via the right carotid artery to introduce a
catheter to the LAD coronary artery. A GE-mobile fluoroscope connected to a video
cassette recorder was used to locate the balloon visually and to record angiograms
throughout the PTCA procedure.

After each procedure, these angiograms were

replayed on a 12 inch monitor to calculate over-inflation ratio (01 ratio), which
denoted the diameter ratio of the inflated balloon catheter (3.0 or 3.5 mm PTCA
catheter inflated with contrast dye) to the diameter ratio of the original coronary
arterial site subjected to PTCA. Throughout all PTCA procedures, attempts were
made to overstretch a 2 cm segment of LAD coronary artery between 30% and 50%
(01 ratio = 1.3 - 1.5). This level of overstretch had previously been shown to
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effectively cause a neointimal proliferative response in the artery without causing
collapse of the vessel (Humphrey, Simmons, Toombs & Shebuski, 1994). This
degree of overstretch was applied twice in 60 second intervals with each inflation
lasting 20 seconds at 8 atmospheres. After all surgical devices were removed and
incision points surgically repaired, effectiveness o_f the PTCA was confirmed by a
repeat angiogram. In order to avoid fibrillation which is usually associated with this
procedure, pigs were treated with a coronary vasodilator (nitroglycerin),
antiarrhythrnic (bretylin), and antithrombotic agent (Aspirin) (Humphrey, Simmons,
Toombs & Shebuski, 1994). At the end of the procedure, each pig was administered
penicillin G intramusculary (1.5 million units) and recovered in their own cages over
2 to 3 hours post-procedure. While pigs were maintained for the next two weeks,
daily oral doses of aspirin (80 mg/day) were given as a post-PTCA treatment.
Histopathology and Morphometric Analysis of Porcine LAD Coronary Artery
Two weeks following the PTCA procedure, pigs were anesthetized with
ketamine/midazolam which was administered intramuscularly. The external jugular
vein was surgically exposed to gain access for a catheter. Heparin (200 U/kg) was
administered systemically followed by Evan's blue dye (1% v/v in physiological
saline) to stain the lesion site at the LAD coronary artery. Evan's blue dye is
excluded by intact endothelium, thus cites of dye uptake indicate balloon-induced
endothelial injury. After sacrificing, the hearts were harvested and retrogradely
perfused at 100 mmHg with physiological saline for 15 minutes. The hearts were

32
then perfused with Omni-fix II fixative (An-Con Genetics, Inc., Melville, NY) for 30
minutes. Three consecutive 1 cm LAD coronary artery segments were taken from
each balloon injured site then fixed in Omni-Fix II fixative for more than 24 hours for
subsequent paraffin embedding. Ten cross-sections were obtained throughout the
entire length of each of the three sample segments_. The sections were stained with
aldehyde fuschin and counter stained with Van Giesson's solution to differentiate the
internal elastic lamina (IEL). On up to 30 cross-sectioned coronary arteries (Evan's
blue stained 20 sections from the 2 cm segment; 10 sections from 1 cm segment with
no Evan's blue stain), morphometric measurements were performed with a computer
aided image analysis system (The Microscope CO., Medina, OH). The degree of
vascular injury caused by PTCA balloon overinflation and the degree of neointimal
hyperplasia was determined by previously established methods (Humphrey,
Simmons, Toombs & Shebuski, 1994).
Indirect Immunofluorescence
Currently, a widely accepted method for anti-SPV antibody titer in serum is
not available, though an attempt was made to measure anti-SPV antibody titer in
porcine serum samples taken at the time of infection, the time prior to PTCA, and at 2
weeks post-PTCA. Immediately after the collection of the serum samples, samples
were incubated at 37 °C for 30 minutes in an attempt to separate serum. Serum
samples were then stored at 4°C until assay.
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Confluent monolayers of PK-15 (Porcine Kidney-15) cells were grown in
eight well chamber slides in RPMI 1640 with 10 % NBCS (Nunc Inc, Naperville, IL).
Cells were then infected with SPV (10 pfu/cell) and incubated at 37° C with 5% CO2
for 36 hours. Microscopic examination at this time was carried out to confirm CPE.
Each well on the slides was then washed 3 times _with PBS containing 1 % (w/w)
gelatin (Bio-Rad Laboratories, Richmond, CA) and cells were fixed for 30 seconds
using ethanol precooled to -20 °C. Wells were rewashed 3 times with PBS/gelatin
immediately prior to sample addition. Porcine serum samples were diluted 1:10,000
with PBS/gelatin and 75µ1 aliquots of this dilution were added to the fixed PK-15
cells and incubated for 2 hours at 37 C0 in a humidified incubator. After the
incubation, the wells were washed 5 times with PBS/gelatin and exposed to 75 µl
aliquots of a 1 :64 dilution (in PBS) of fluorescein isothiocyanate (FITC) labeled
rabbit anti-pig IgG (Sigma, St. Louis, MO) and incubated for 1.5 hours at 37 C0 in a
humidified incubator. The wells were then washed 5 times with PBS/gelatin, mounted
in Vectar Shield (Vectar Laboratory, Burlingame, CA), and observed under UV
microscope (Nikon, Tokyo, Japan). Intensity of fluorescence was measured by
recording exposure time required to activate camera. Therefore, in theory, serum
levels of anti-SPV antibody should be inversely proportional to the recorded exposure
time. In short, the higher the exposure time was, the lower the antibody titer in serum
sample was.

34
ELISA
In addition to the immunofluorescent procedure, in order to titer anti-SPV
antibody in serum samples, enzyme linked immunosobent assay (ELISA) was carried
out as described in published literature (Hyman & Perombelon, 1990). Confluent
monolayers of PK-15 cells were infected at multiplicity of 10 pfu/cell or mock
infected and incubated at 37 °C with 5% CO2 for 36 hours. After the incubation,
supernatant and cells were recovered and centrifuged at 1500 xg (IEC PR-6000
refrigerated superspeed centrifuge) for 5 minutes. Then supernatants were decanted
and deionized water was added to pellet. The pellet was frozen and thawed three
times and centrifuged again at 1500 xg (IEC PR-6000 refrigerated superspeed
centrifuge at 1000 rpm) for 15 minutes. Supernatants were saved and mixed with the
same amount of 2x coating buffer. Then 50 µl aliquots of the mixtures were
dispensed to each well of Immulon II 96 well plates (Flow Laboratories, Horsham,
PA) and incubated for overnight at 37 C0 in a humidified incubator. After the
incubation, the plates were washed three times with PBS with 0.05% (v/v)
polyoxyethylenesorbitan monolaurate (Tween 20) (Sigma, St. Louis, MO) followed
by addition of 100µ1 aliquots of blocking buffer (PBS- 0.1% gelatin) to each well.
The plates were left at room temperature for one hour, then the plate was washed two
times with PBS-Tween 20. Final wash was decanted and 100 µl aliquots of each
1: 10,000 diluted pig serum sample (diluted in blocking buffer) were introduced to
designated wells. Hyperimmune serum kindly provided by Dr. Richard Moyer
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(University of Florida, Gainesville, FL) was diluted 1: 100 in blocking buffer. After
the addition, the plates were incubated at room temperature for 90 minutes. The plates
were then washed five times with PBS-Tween 20 (0.05%). 50µ1 aliquots of goat anti
pig lgG peroxidase conjugated antibody, diluted 1 :10,000 in blocking buffer, was
added to each well and incubated at room temperature for 60 minutes, followed by
five washes with PBS-Tween 20 and a wash with deionized water. Substrate made
with OPD (4mg/10ml), DMSO (50 - 100 µl), and Phosphate-Citrate buffer (0.05M,
pH 5.0) was mixed with H2 O2 (100µ1/lOml) and 50µ1 aliquots of the mixture was
added immediately to the plates. The plates were incubated at room temperature for
30min in a dark place and reaction was stopped by addition of 2M H2SO4 (50µ1/well).
The plate was then observed with a microplate reader (Bio-Rad, Richmond, CA) at an
absorbance of 450 nm.
Production of Monoclonal Antibody (mAb)
Production of Hybridomas
Methods used for production and selection of hybridomas have been described
m detail elsewhere (Ouchi, Fujiwara, Hatano, Yamada & Nii, 1992). SPV was
produced by following a protocol described above. At week intervals for four weeks,
female Bulb/c mice (Charles River, Kalamazoo, MI) were immunized with PK-15
cells infected with SPV (10 pfu/cell). After the four weeks, the mice received a
booster injection intraperitoneally with a mixture of PK-15 cells infected with SPV.
Five days after the booster injection, the mice were sacrificed and the spleen cells
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were harvested. The spleen cells were fused with the mouse myeloma cell line
P63Ag8 (American Type Culture Collection, Rockville, MD) pretreated with 8
azaguanine using polyethylene glycol (Gibco Laboratories, Grand Island, NY). Fused
cells were seeded on 96 well dishes and hybridomas were selected with a medium
containing hypoxantine / aminopterin / thymidine (HAT medium). Hybridomas were
screened for the presence of anti-SPV antibodies by indirect immunofluorescent tests.
Indirect Immunofluorescence
This test was done with a slight modification of the indirect
immunofluorescent procedure described above. PK-15 cells cultured to confluence on
coverslips were infected with SPV at a multiplicity of infection of 10 pfu. At 48 hours
postinfection, infected cells on coverslips were washed with serum free RPMI 1640
with antibiotics and fixed for 30 seconds using 200 proof ethanol precooled to -20° C.
The coverslips were then washed with PBS-gelatin (0.01%) several times. The
supernatants of hybridoma cultures (50 µ1/coverslip) were used as the primary
antibody and incubated for 2 hours at 37 C0 in a humidified incubator. 50 µ l aliquots
of a 1 :64 dilution (in PBS) of fluorescein isothiocyanate (FITC) labeled rabbit anti
pig lgG (Sigma, St. Louis, MO) was used as the secondary antibody and incubated
for 2 hours at 37 C0 in a humidified incubator. The coverslips were then washed 5
times with PBS/gelatin, mounted in Vectar Shield (Vectar Laboratory, Burlingame,
CA), and observed under UV microscope (Nikon, Tokyo, Japan).

RESULTS
Viral Polypeptides
SPV Replication in Tissue Culture
Only four published studies have described SPV infection in tissue culture
systems (Kasza, Bohl & Jones, 1960; Massung & Moyer, 1991a; Massung & Moyer,
1991b; Massung, Jayarama & Moyer, 1993). According to these studies, SPV is a
relatively slow growing virus compared to other poxviruses.
In order to assess the cytopathology of SPV infection, PK-15 cells were
infected with SPV. The cytopathic effect (CPE), which denotes changes in the
microscopic appearances of cultured cells following virus infection, was examined.
Plaque formation was also observed. Plaques, in a confluent PK-15 cell monolayer,
were clear circular areas, approximately 2 mm in diameter, and resulted from cell
rounding and lysis of cells 10 days postinfection.
A confluent monolayer of PK-15 cells was infected with SPV at 0.1 pfu/cell
followed by adsorption on a rocker table for one hour. These infected cells were
incubated at 37° C with 5% CO2• CPE was evident 7 days post-infection and an
important distinctive feature of the CPE was the presence of intracytoplasmic
inclusions and vacuoles in the cytoplasm of infected cells. In parallel experiments,
CPE was evident 2 days post-infection when monolayers were infected with 10
37
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pfu/cell. Infection with SPV at a multiplicity of 20 pfu/cell also produced a CPE 2
days post-infection.
Synthesis of Swinepox Virus Protein
Most of the studies for SPV protein production have been limited to DNA
sequence analyses for prediction on what proteins would be expressed upon SPV
infection (Massung & Moyer, 1991a; Massung, Jayarama & Moyer, 1993). Proteins
secreted from SPV infected cells have never been analyzed or characterized in the
published literature.
Experiment designed to determine early and late SPV proteins were
conducted. Monolayers of PK-15 cells in 60 mm dishes were either mock-infected or
SPY-infected. Multiplicity of infection was 20 pfu/cell. After the initial infection,
monolayers were incubated in maintenance medium for 2 hours followed by washes
with serum-free RPMI 1640. The monolayers were then starved in methionine-free
medium for one hour prior to labeling with

[

35

S] methionine. In addition to

[

35

S]

methionine, Cytosine P-D-Arobinofuranoside (AraC), which blocks DNA synthesis,
was also added to monolayers to monitor the synthesis of early viral proteins. Both
pellet (total protein) and supernatant samples (secretory proteins) were collected as
described in Materials and Methods. Proteins were then separated on 11.5% SDS
PAGE. Samples were analyzed under reducing (with 2-mercaptoethanol) and non
reducing conditions (without 2-mercaptoethanol).
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After the gel electrophoresis, autoradiography was performed to visualize proteins.
Cytoplasmic extracts from SPY-infected PK-15 cells, 22 hours post-infection,
revealed no visible viral proteins (Figure 1, Lanes H and I), as compared to mock
infected cells (Figure 1, Lane G). A major protein (35 kDa) is secreted from infected
cells 22 hours post-infection (Figure 1, Lanes B, C, _E, and F). The protein appeared in
supematants from SPY-infected cells treated with AraC (Figure 1, Lanes C and F)
and the protein continued to appear in supematants from SPV-infected cells not
treated with AraC (Figure 1, Lanes B and E). Therefore, the protein is classified as an
early protein. Also the protein did not appear in supematants from mock-infected
cells (Figure 1, Lanes A and D).
Post-Translational Cleavage of Viral Polypeptides
It has been previously shown (Katz & Moss, 1970) that during vaccinia virus
maturation at least three precursor polypeptides are proteolytically cleaved into
product polypeptides which become structural components of the virus. Almost all
poxviruses examined thus far demonstrate this activity (Moss, 1996). Since no data is
available on SPV maturation, we were interested in determining whether post
translational cleavage plays any role in SPV maturation. To determine this, a pulse
chase experiment was designed. PK-15 cells were infected with 20 pfu/cell with SPV.
At 8hours post-infection, cells were washed and starved in methionine-free medium
for one hour and pulse labeled with [35 S] methionine (50µCi/ml) for one hour. The
cell pellet was removed at the end of the pulse. The other pulse labeled sample was
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Lanes

A

B

C

D

E

F

G

H

I

66.2
42.7
31.0

21.5

14.4

t

M.W.
(kDa)

Figure 1.

+2ME

- 2 ME

Synthesis of Viral Polypeptides From SPV Infected Cells.
Autoradiogram of 11.5 % Polyacrylamide gel electrophoresis.
Samples are supernatant from mock-infected (A,D), supernatant from
SPV infected cells 22 hours post-infection (B,E), supernatant from
SPV infected cells with a presence of AraC (C,F), cytoplasmic extract
from mock-infected cells (G), cytoplasmic extract from SPV infected
cells 22 hours post-infection (H), cytoplasmic extract from SPV
infected cells with a presence of AraC (I). +2ME indicates a presence
of 2- mercaptoethanol and -2ME indicates an absence of 2mercaptoethanol.

41
chased for 12 additional hours. Polypeptides present in the total cytoplasm (pellet)
were solubilized with SDS and 2-mercaptoethanol and separated by polyacrylamide
gel electrophoresis. An equal amount of TCA precipitable protein was loaded into
each lane. Radioactive bands were detected by autoradiography.
Result from the autoradiogram (Figure 2), an evidence of post-translational
cleavage was found. A polypeptide band (8.6 k.Da) appeared in the SPY pulse sample
(Figure 2, SPY pulse indicated with ➔) and appeared as faded polypeptide bands (35
k.Da) in the SPY chase sample (Figure 2, SPY chase indicated with �*).

The

polypeptide band was not observed in the mock pulse sample (Figure 2, mock pulse).
Also, a polypeptide band appeared in the SPY chase sample (Figure 2, indicated with
�*), which was not detected in the mock pulse sample and the SPY pulse sample.
These results suggest that the polypeptide was cleaved from precursor polypeptides.
The SPY Secretory Polypeptide Differed From TPY 38 k.Da Polypeptide
An earlier report from our laboratory (Essani, Chalasani, Eversole, Beuving
& Birmingham, 1994) describes a 38 k.Da secretory protein from TPY infected cells.
In order to determine if a major secretory protein (35 k.Da) found in SPY-infected
samples differs from the 38 k.Da polypeptide found in TPY, owl monkey kidney
cells (OMK) were infected with TPY and PK-15 cells were infected with SPY. Both
concentrated supernatant from TPY-infected OMK cells and SPY-infected PK-15
cells were solubilized and proteins were resolved by electrophoresis in a 11.5 %
polyacrylamide gel. As shown in Figure 3, the tanapox virus 38 k.Da protein was
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31.0 kDa21.5 kDa-

14.4 kDa-

Figure 2. Post-Translational Cleavage of Viral Proteins.
Equal amount of TCA precipitable counts were loaded to each
lane on 11.5% Polyacrylamide gel. Radioactive bands were
demonstrated by autoradiography. An original gel was
exposed for 120 hours. Post-translational cleavage of a
polypeptide was detected. A polypeptide indicated with a
solid arrow appeared in the SPY pulse sample and appeared as
a faded band in the SPY chase sample, suggesting post
translational cleavage. Also an open arrow indicates a
polypeptide appeared in the SPY chase sample, which did not
appear in the SPY pulse sample.
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M.W.
66.2 kDa
42.7 kDa

..

38 kDa TPY
Protein

21.5 kDa

14.4 kDa

Figure 3.

Comparison Between a TPY 38 kDa Secretory Protein and a Major
Secretory Protein Found in Superntant From SPY-Infected PK-15
Cells.
An open arrow (points to bands on SPY LS and SPY ES) indicates a
major secretory protein from SPY-infected PK-15 cells (35 kDa). A
38 kDa secretory protein in supernatant from TPY infected OMK
cells is indicated on TPY lane with a solid arrow. The SPY secretory
protein (35 kDa) clearly differs form the TPY 38 kDa protein. Mock.
S indicates supernatant from mock-infected Pk-15 cells. SPY. LS
indicates supernatant from SPY-infected cells and the sample was
harvested at 22 hours post-infection. SPY. ES indicates that
supernatant from SPY-infected PK-15 cells and the sample was
treated with AraC. PK-15 cells were infected with SPY and OMK
cells were infected with TPY under same conditions. Supernatants
were collected and concentrated. Samples were resolved by SDS
pAGE. A autoradiography was performed by exposing a X-OMAT
film on dried gel for 115 hours. (M.W. = Molecular Weight.)
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different from a major polypeptide (35 kDa) discovered in the supernatant obtained
from SPY-infected PK-15 cells. As described below, the unavailability of swine
cytokines prevented us from demonstrating any anti-cytokine activity associated
with the 35 kDa SPY secretory protein.
Anti-Interferon-y Activity in the Supematants From SPY-Infected Cells
Many viruses in the family Poxviridae are known to secrete polypeptides
which bind to interferon gamma (INF-y).

Myxoma virus (Upton, Mossman &

McFadden, 1992) and vaccinia virus (Symons, Alcami & Smith, 1995) are known
poxviruses which encode soluble INF-y receptors.

In myxoma virus, the IFN-y

receptor homologue is a major secretory polypeptide from infected cells and binds to
IFN-y and competitively inhibits the binding of INF-y to original receptor (Upton,
Mossman & McFadden, 1992). In order to determine whether SPY encoded soluble
receptors of human recombinant interferon gamma (hlFN-y), virus free supematants
from mock-infected or SPY infected cells were incubated on PK-15 cells with 100
units of hlFN-y and these cells were subsequently challenged with SPY at 100
pfu/well. If SPY secretory proteins bind to hIFN-y, antiviral activity of hlFN-y would
be inhibited and 100 plaques should be observed after a subsequent challenge with
SPY 100 pfu/cell.
As shown in Table 1, several attempts were made to clarify the ability of
putative SPY encoded secretory polypeptides to neutralize hlFN-y antiviral activity.
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Table 1
Results of Interferon Gamma Assay
Well
IFNy

1
0 units

Protein
Samples
SPV
Infection
Experiment
1
Experiment
2
Experiment
3

3
50 units

4
50 units

5
0 units

6
0 units

Mock 5x
Su;eer
100 pfu

2
100
units
None

None
100 pfu

SPV 5x
Su;eer
0 pfu

None

100 pfu

. SPV5x
Su;eer
100 pfu

35 pfu

16.5 pfu

17.5 pfu

37.5 pfu

0 pfu

0 pfu

78 pfu

68.5 pfu

82 pfu

86.5 pfu

0 pfu

0 pfu

92.5 pfu

77 pfu

79.5 pfu

76 pfu

0 pfu

0 pfu

0 pfu

Confluent monolayers of PK-15 cells in 6 well dishes were treated with mixtures of
IFN-y and protein samples as indicated. Subsequent infection with SPV or mock took
place as indicated. Following incubation for 14 days in overlay medium, monolayers
were fixed with formaldehyde and stained with 1 % crystal violet. Plaques were
counted under a microscope.
The negative results may suggest that anti-IFN-y activity 1s species specific.
Unavailability of swine IFN-y prevented additional studies.
Anti-Tumor Necrosis Factor-a Activity in the Supematants From SPV Infected Cells
Myxoma virus is known to encode T2 protein which is capable of inhibiting
rabbit TNF-a (Schreiber & McFadden, 1994). TNF-a is an important component of
the immune system which induces mitogenic effects on vascular endothelial cells and
produce acute inflammation with neutrophil infiltration (Stites & Terr, 1991). In an
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attempt to verify whether SPV encodes soluble TNF-a receptor homologues, a TNF
a assay was carried out using hTNF-a. Because swine TNF-a was not available,
anti-TNF-a activity of SPV encoded secretory proteins was estimated by assaying for
expression of cell adhesion molecules (CAMs) on human umbilical vein endothelial
cells (HUVEC). Human TNF-a (hTNF-a) is known to up-regulate the expression of
ICAM-1, VCAM-1, and E-Selectin in HUVEC upon binding of hTNF-a to cellular
TNF-a receptors (Williams & Hellewell, 1992). Also, ICAM-2 is known to be
expressed constitutively (Williams & Hellewell, 1992). If SPV encodes secretory
proteins that bind to hTNF-a as shown in myxoma virus, up-regulation of ICAM-1,
VCAM-1, and E-Selectin on HUVEC would be hindered. By measuring expression
of CAMs after addition of a mixture of hTNF-a and SPV encoded secretory proteins,
it should be possible to establish whether these proteins are capable of inhibiting
hTNF-a.
Five fold concentrated supematants from mock-infected and SPY-infected
samples were mixed with fixed units of hTNF-a prior to its application to HUVEC
cells. The mixture was added to HUVEC cells followed by incubation and fixation of
treated HUVEC. ELISA was performed to measure the expression of CAMs. Mouse
anti-CAMs IgG antibody was used as primary antibody and alkaline phosphatase
conjugated goat anti-mouse IgG was added as secondary antibody followed by
incubation and washing. Chromogenic substrate, p-nitrophenyl phosphate, was added
and absorbance at 405 nm (in the microtiter plates) was read using a fluorescence
microtiter plate reader. Results were recorded with the aid of peripheral computer
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software. The results in this case were also negative, demonstrating that none of the
secretory proteins from SPV infected cells can bind to hTNF-a.
Expression of ICAM-1 was not inhibited as the amount of concentrated
samples of SPV encoded secretory proteins increased (Figure 4. C). Initially it
appeared that SPV secretory proteins reduced .ICAM-1 expression in a dose
dependant manner. Increased concentration of mock-infected samples also reduced
expression of ICAM-1 in a similar manner. Similarly, expression of VCAM-1 was
not reduced by the inhibition of hTNF-a by SPV secretory proteins (Figure 4. A). As
observed with ICAM-1, it again appeared that increasing doses of SPV encoded
secretory protein inhibited TNF-a. This may have resulted reduced expression of
VCAM-1 but the reduction may also have been due to the use of mock-infected
samples. With only hTNF- a addition, E-selectin was stimulated to show more than
0.3 in 405 nm absorbance (Figure 4. B). When absorbances from zero tol00 µl SPV
secretory proteins with hTNF-a were compared, no drastic reduction of E-selectin
expression was observed. It appeared that addition of 200 µl SPV secretory protein
with hTNF-a reduced the expression of E-selectin, but this reduction was also
evident with mock-infected samples.

Therefore, it is not clear if SPV encoded

secretory proteins were capable of inhibiting hTNF-a.

48

(A) VCAM-1 w/ TNF

(B) E-Selectin w/ TNF
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(A) VCAM-1 (B) E-Selectin (C) ICAM-1 expressions. HUVEC cells
were stimulated with TNF-a with concentrated supernatant from SPV infected cells or mock-infected cells.
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Anti-Interleukin-lB Activity in the Supematants From SPV Infected Cells
A soluble receptor for ILl-P is encoded by vaccinia virus (Alcami & Smith,
1992) and cowpox virus (Spriggs, Hruby, Maliszewski, Pickup, Sims, Buller, and
Vanslyke, 1992). IL-1p plays an important role in the production ofantibodies by B
cells (Stites & Terr, 1991). IL-IP is also known to up-regulate expression ofVCAM1, ICAM-1, and E-Selectin. Therefore, the same methods used for TNF-a assays
were used to determine whether SPV encodes a similar soluble receptor for IL1-p. It
was not possible to verify the existence of a SPV encoded soluble inhibitor ofhuman
recombinant IL-1p.
Five fold concentrated supernatant from mock-infected and SPY-infected
samples were mixed with fixed units of IL-Ip. The mixture was added to HUVEC
cells and expression ofCAMs were assayed. Although several attempts were made to
stimulate HUVEC cells with Interleukin 1p (IL-1P), it was not successful to up
regulate expression of all CAMs to satisfactory levels. Only E-Selectin and ICAM-1
showed satisfactory up-regulation with the addition ofIL-1p.
It was clearly shown that 0 to 100 µl addition of SPV secretory protein with
IL-lP did not down-regulate the expression of ICAM-1 (Figure 5. A). When only
SPV secretory protein was added to HUVEC cells, the expression of ICAM-1
returned to its base expression levels. This phenomenon was also observed with
concentrated supematants from mock-infected cells. It was also shown that Oto 100
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Figure 5.

Inhibition of Expression of CAMs With SPV Encoded Secretory Proteins
(IL-Ip stimulated).
(A) Expression of VCAM-1 (B) Expression of E-Selectin. HUVEC cells
were stimulated with IL-1 p with concentrated supernatant from SPVinfected cells or mock-infected cells. NS = no stimulation (no IL-Ip
stimulation). 0 = No supernatant, IL-1 p only. 200 = Supernatant only,
no IL-IP.
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µl addition ofSPV secretory protein with IL-1 p did not down-regulate the expression
ofE-Selectin with dose dependant manner (Figure 5. B).
Anti-Restenosis Activity ofViral Polypeptides
Poxvirus Secretory Polypeptides as an Anti-Restenosis Agent
Percutaneous transluminal coronary angioplasty (PTCA) is a common
treatment for coronary artery diseases caused by artherosclerotic plaque deposition.
After the vascular injury caused by PTCA, inflammatory responses are known to be
major contributors for restenosis, which result in neointimal formation due primarily
to proliferation and migration of smooth muscle cells. The inflammatory responses
involve many inflammatory enzymes and thrombotic enzyme cascades, which have
serine proteinase activity and are regulated by serine proteinase inhibitors. The serine
proteinase inhibitor, SERP-1, was verified as a potent inhibitor of restenosis (Altieri,
1995). Lucas et al. (1996) obtained the purified serine proteinase inhibitor (SERP-1),
which was a myxoma virus encoded secreted glycoprotein, to observe effects on
neointimal formation and plaque growth following balloon injury in rabbits. Plaque
development was reduced by inhibition of serine proteinase activity and was
characterized by a focal decrease in macrophage infiltration immediately after the
balloon angioplasty (Lucas, Liu, Macen, Nash, Dai, Stewart, Graham, Etches,
Boshkov, Nation, Bumen, Hohman & McFadden, 1996).
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In order to determine if SPV encodes secretory proteins which exhibit similar
effects on restenosis, pigs were infected either with SPV or vehicle a week before
PTCA. Rather than local delivery of a specific SPV secretory protein to the site of
PTCA, systemic SPV infection was chosen, since purified SPV encoded secretory
proteins were not available.
Numbers of Pigs Included in This Study
Within a group of 22 pigs, 19 pigs survived the entire two weeks recovery
after PTCA balloon over-inflation. Two of the SPV infected pigs died from lethal
arrhythmia due to acute balloon failure. One of control pig died from respiratory
failure at the time of post PTCA recovery. From the 19 surviving pigs, a total of 2
pigs (1 control and 1 SPV infected) were excluded from analysis, because they
developed abnormal double-lumen morphorogy at the balloon-injured site. Also, one
SPV infected pig was excluded from analysis due to an unusually large injury index.
In total, data from 8 control and 8 infected pigs were utilized to examine effects of
SPV infection on restenosis.
Symptomology in Swine
Since poxviruses cause lesion formation on their hosts, symptoms on pigs
were carefully examined as a part of verification of SPV infection. As shown in
Figure 6, all pigs infected with live SPV developed a lesion at the site of
subcutaneous injection site within one week post-infection. However, by three weeks
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Figure 6.

A Photograph Taken on a SPY-Infected Female pig a Week Post
Infection (at the time of PTCA).
An arrow indicates the injection site, which is characterized by papule
formation. This papule formation at injection site was the most
common symptom for SPV infected pigs. Also note that the papule
formation is limited to the injection site. Papule like structures appear
above the injection site are nipples.
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post-infection, only 2 out of 8 SPY-infected pigs sustained escalated skin lesions
throughout the groin area and the axillary regions. On the other hand, none of the
mock-infected pigs developed characteristic pox lesions at the injection site. It has to
be noted that 2 out of 8 mock-infected pigs showed unusual rashes throughout their
inguinal areas.
Morphometric Analysis of Swine LAD Coronary Arteries
In order to assess the effects of SPY infection on restenosis, cross-sections of
balloon-injured porcine LAD coronary arteries were morphologically compared
between mock-infected group and SPY-infected group. Table 2 shows the magnitude
of arterial over-stretch (Over-inflation or 01 ratio), the severity of internal elastic
lamina (IEL) rupture (=injury index), neointimal and medial areas, total areas,
demarcated by the external elastic lamina (EEL), and the extent of neointimal
hyperplasia (proliferation index or NI/M) measured in balloon-injured porcine
coronaly arterial segments two weeks after PTCA over-inflation. The mean 01 ratios
were similar between the mock-infected (1.43) and SPY-infected (1.41) groups.
Alternatively, the degree of vascular injury induced by this degree of over-stretch was
also similar between groups, as mean injury indexes of the mock-infected and SPY
infected pigs were 25.9 ± 2.3 % and 25.7 ± 3.7 %, respectively. The magnitude of
neointimal proliferation in terms of the NI/M ratio was 18 % lower in the SPY
infected group (0.85 ± 0.09) compared to the NI/M ratio observed in the mock
infected group (1.04 ± 0.16), but this difference was not statistically significant.

Table 2
Morphological Analysis of Balloon-Injured Porcine Coronary Artery Segments Harvested 2 Weeks After Intentional
PTCA Over-inflation.
Group
Control
(Mock
Infected)
Group
Number = 8
SPV Infected
Group
Number = 8

Over
Infration
Ratio
1.43 ± 0.01

Injury Index
(IEL*/IEL X
100�
25.9 ± 2.3

Neointimal
Area
2
(mm )
0.49 ± 0.07

Medial Area
2
(mm )

EEL** Area
2
(mm )

Proliferation Index
(NI/M)

0.50 ± 0.03

2.82 ± 0.14

1.04 ± 0.16

1.41 ± 0.02

25.7 ± 3.7

0.40 ± 0.04

0.48 ± 0.02

2.80 ± 0.12

0.85 ± 0.09

*Internal Elastic Lamina
**External Elastic Lamina

Vl
Vl
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Figure 7 represents the linear regression arialysis that was performed to
compare the severity of injury to the subsequent degree of neointimal proliferation in
the two groups. Although the slope of linear regression line of the mock-infected
group (3.65 ± 1.91, r = 0.52) was 2.5 fold larger than the slope of linear regression of
the SPY-infected group (1.45 ± 1.22, r = 0.71), the _overall relationship between the
extent of injury arid consequent proliferation was not statistically significarit. (p=0.35
according to the general linear arialysis).
A typical cross-section from SPY-infected pig LAD coronary artery is shown
in Figure 8. Also, a typical cross-section of mock-infected pig LAD coronary artery
is shown in Figure 9. When those two figures are compared, the degree of neointimal
smooth muscle cell proliferation at rupture sites do not appear to differ from each
other.
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Linear regression analysis illustrating the positive correlation between
the severity of vascular injury (Injury index) and the extent of
neointimal proliferation (Proliferation Index) in balloon-injured
coronary arteries obtained of mock- and SPV- infected domestic
feeder pigs. Differences in the slopes of the regression lines were not
statistically significant between groups (p=0.35 via the general linear
models procedure).

58

Figure 8.·

A Typical Cross Section of a LAD Coronary Artery From a Pig in a
SPV Infected Group (n=8).
An area indicated with an arrow is a rupture site made by the balloon
over-inflation. The area also shows neointimal cell proliferation, which
is a main characteristic of the restenosis. Notice that degree of the
neointimal cell proliferation does not differ from that of mock-infected
pig.
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Figure 9.

A Typical Cross Section of a LAD Coronary Artery From a Pig in a
Mock Infected Group (n= 8).
An area indicated with an arrow is a rupture site made by the balloon
over-inflation. The area also shows neointimal cell proliferation, which
is a main characteristic of the restenosis. Notice that degree of the
neointimal cell proliferation does not differ from that of SPY-infected
pig.

DISCUSSION
SPV Polypeptides
Swinepox Virus
Although SPV was first appeared in the early 19th century as a common
disease in swine population, very little was known about the virus. Besides previous
DNA sequence analyses and clinical studies, no additional studies were conducted on
SPV encoded secretory proteins.

This is the first attempt to demonstrate SPV

encoded secretory polypeptides. No other studies have ever clarified biological
activities of SPV encoded secretory proteins. The major limitation in this study was
that almost no swine cytokines are commercially available.
It is evident that SPV is a relatively slow growing virus as compared to
vaccinia virus (Massung & Moyer, 1991a). The cytopathology of SPV infection in
PK-15 cell monolayers is characterized by CPE and plaque formation.
Intracytoplasmic inclusions and vacuoles in cytoplasm characterize the CPE. Plaques
are clear circular areas with a diameter of 2 mm in a confluent PK-15 cell monolayer.
A major 35 kDa SPV encoded secretory protein was found exclusively in
supematants from SPY-infected PK-15 cells (Figure 3. SPY.LS & SPY.ES). This
protein was not detected in mock-infected cells or TPV infected cells. The protein is
virologically classified as an early polypeptide as it is synthesized in the presence of
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cytosine P-D-arobinofuranoside (AraC), an inhibitor of DNA synthesis (Figure 1,
Lane C).
An earlier study showed that SPV exhibits highly attenuated phenotype and
mild infections in swine population as described above. Analysis on the SPV DNA
sequences of the highly variable near-terminal regions suggested that approximately
20,000 base pairs of DNA near the left terminus including host range genes C7L and
KlL of vaccinia virus is clearly absent in SPV (Massung, Jayarama & Moyer, 1993).
This finding suggests that SPV exhibits limited host range and ineffectiveness to
infect mammals other than swine.
Likewise, homologues of genes encoding complement C4b binding protein,
secreted protein N 1L, and vaccinia virus growth factor found in the left terminal
region of vaccinia virus were not found in SPV DNA (Massung, Jayarama & Moyer,
1993). Therefore, it is reasonable to believe that SPV has lost a part of left terminal
region responsible for its pathogenesis during a course of evolution.
Anti-Cytokine Activities Secreted From Poxvirus Infected Cells
In order to suppress the multiplication of viruses inside animal body, immune
system of vertebrates has developed non-specific immune factors such as
complement, interferons and natural killer cells to halt virus replication. Cytotoxic T
cells and antibodies further eradicate viruses. Because of selective pressures, certain
proteins that are secreted from poxvirus-infected cells enhance the ability of the virus
to replicate and deter host immune responses (Barinaga, 1992).

Poxviruses are
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reported to encode secretory proteins which inhibit cytokines important for onset of
inflammatory responses (Moss, 1996).
In order to characterize biological activities of the SPV encoded secretory
polypeptides, studies of anti-cytokine activities are important.

It has been

demonstrated that tanapox virus (TPV) encoded 38 kDa polypeptide, which is an
early gene product, binds to hIFN-y, hIL-5, and hIL2 (Essani, Charasani, Eversole,
Beuving & Birmingham, 1994). Also the polypeptide was recently reported to bind
to hTNF-a (Paulose & Essani, Unpublished data). Since a major 38 kDa secretory
polypeptide found exclusively in supernatant of TPV-infected owl monkey kidney
cells exhibited multiple anti-cytokine activities, there was a great possibility that SPV
encodes similar polypeptides upon infection of PK-15 cells.
Throughout our study, a major problem was the unavailability of swine
cytokines, therefore we used human cytokine products. As described below, SPV
secretory polypeptides show no anti- human cytokine activities. When we consider
the fact that SPV is capable of causing disease in swine, SPV must encode secretory
polypeptides against swine cytokines. The negative results in this study suggest that
SPV encoded secretory polypeptides may be species specific. Hence, we were unable
to demonstrate anti-cytokine activities using a variety of human cytokines.
Evidence for this notion comes from studies demonstrating an ORF C6L in
the left terminus of SPV genome that is known to encode a polypeptide with 274
ammino acids with a molecular weight of 32.3 kDa (Massung, Jayarama & Moyer,
1993). The C6L ORF shows only 25% homology to the hIFN-y receptor (Massung,
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Jayarama & Moyer, 1993). C6L was also reported to have a putative hydrophobic
leader sequence and likely to be secreted from infected cells.
Interestingly enough, approximate molecular weight of 35 kDa polypeptide
that we found exclusively in SPY-infected cell supernatant, is close to the suggested
molecular weight of ORF C6L encoded polypeptide, hence careful comparisons and
examinations of both polypeptides are required to truly understand anti-hlFN-y
activities of SPV encoded secretory polypeptides.

Considering the species

specificity, we expect that the SPV C6L encoded polypeptide will exhibit high
homology to swine IFN-y. It would be interesting to purify the 32.3 kDa polypeptide
and carry out experiments to see if the polypeptide is able to bind to either human
recombinant IFN-y or swine IFN-y.
Similarly no DNA sequence homologues for hTNF-a receptors were found in
either the left terminus or the right terminus of the SPV DNA. The question, whether
the swine TNF-a receptor is totally different from that of humans, remains an open
question. SPV KIR ORF showed only 32.1% homology to cowpox virus 38 kDa
protein (Massung, Jayarama & Moyer, 1993), which was shown to inhibit hlL-lP
converting enzyme to inhibit IL-1p activity (Ray, Black, Kronheim, Greenstreet,
Sleath, Salvesen & Pickup, 1992).
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Anti-Atherosclerotic Activity of SPV Encoded Polypeptides
Atherosclerosis Study
It has been thought that initiation of restenosis involves activation of
inflammatory and thrombotic cascades, which are commonly regulated by serine
proteinase enzymes and inhibitors (Lucas, Liu, Macen, Nash, Dai, Stewart, Graham,
Etches, Boshkov, Nation, Bumen, Hohman & McFadden, 1996).

Inflammatory

cascades also include adhesion of leukocytes after PTCA balloon over-inflation,
which is induced by cytokine-leukocyte signaling. Many poxviruses encode proteins
which inhibit or bind to host cytokines.

Those proteins are known as

immunomodulatory proteins. In a case of myxoma virus, the virus secretes a serine
proteinase inhibitor (SERP-1) upon infection, which inhibits serine proteinase like
plasminogen (Macen, Upton, Nation & McFadden, 1993; Upton, Macen, Wishart &
McFadden, 1990).

Local introduction of purified immunomodulatory proteins

encoded by vaccinia virus has been reported to inhibit neointimal hyperplasia induced
by PTCA ballon over-inflation (Lucas, Liu, Macen, Nash, Dai, Stewart, Graham,
Etches, Boshkov, Nation, Bumen, Hohman & McFadden, 1996). In our study, based
on the fact that all poxviruses secrete some sort of anti-cytokine polypeptides upon
infection, SPV was assumed to secrete similar polypeptides. Since SPV encoded
polypeptides had never been characterized, systemic SPV infection on domestic
feeder pigs was used to see if SPV induced immunosupression could cause an anti-
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proliferative effect in a porcme model of neointimal proliferation which mimics
restenosis in humans.
Morphological Tests to Reveal no Effects of SPV Infection on Restenosis
In order to measure the degree of neointimal proliferation, at three weeks
post-infection with either vehicle or SPV, pig LAD coronary artery were harvested
and morphological examination was performed. Subcutaneous administration of SPV
to domestic feeder pigs a week prior to PTCA balloon over-inflation did not reduce
neointimal hyperplasia compared to mock-infected pigs.

When NI/M ratio was

measured, the magnitude of neointimal proliferation was 18 % lower in the SPV
infected group compared to the mock-infected group (Table 2). This difference was
not considered statistically significant. Also linear regression analysis was conducted
to compare the severity of balloon injury to the resultant degree of neointimal
proliferation in the two groups (Figure 7). Though the analysis revealed that the
regression was larger in mock-infected group compared to SPY-infected group, the
difference was not statistically significant.
Serological Examination
Unavailability of a reproducible serological technique to demonstrate anti
SPY antibodies restricted our ability to confirm the experimental SPY infections in
pigs. It also restricted our ability to demonstrate that the pigs employed in these
experiments were free from SPY.
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Unless immunomodulatory polypeptides encoded by SPV are purified and
SPV-free pig populations are available, real effects of the polypeptides on restenosis
in pig will remain unknown. It has been reported that ORF KlR in the right terminus
of SPV DNA shows homology to members of serine proteinase inhibitor protein
family (Massung, Jayarama & Moyer, 1993). The KlR homology was highest with
vaccinia virus spi-2, which was also found in cowpox virus as a 38 kDa protein
(crmA). The crmA protein was a serine proteinase inhibitor and was shown to inhibit
the cellular IL- 1 p converting enzyme (Ray, Black, Kronheim, Greenstreet, Sleath,
Salvesen & Pickup, 1992). If serine proteinase inhibitor is an only factor to reduce
restenosis as reported in a case of the myxoma virus SERP-1 protein, it would be
interesting to purify K 1 R protein to conduct further restenosis study.

Appendix A
An Approved Animal Use Protocol From the
Corporate Animal Care and Use Committee,
Pharmacia and UpJohn Company
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1ST RENEWAL JAN 19 REC1

Illt"TER.'lfAL USE ONLY
D_,. Upon Dt■poeal

RENEWAL OF ANIMAL USE PROTOCOL (AUP) FORM

Corporate Animal W■llan Committ.■e (CAWC)
The Upjohn Company
1.
2.
3.
4.
5.

Pl- not.■ an AUP form c■.n be r■n.wd • mu:imum a( 2 time■ be(or■ it mu.■ t be r■WTittan. NOT TO BE USED FOR
CATEGORY V'S.
R.ecurn the r■nawal rorm and • copy of,- oriciuJ authorised AUP form and az,y amendment.■ to: A.S&I.S Main om
7273-25-7.
For ■...ta- with an AUP (arm call 5-7814. Animal arden will not be procaa■■d without an authorization ...i.. New code■
an r...i..t ■wry 12 month■•
If the rorm L■ not compl■t.■d adaqu■t■ly and lepbly, it will be nttum■d to the re■pan■ibl■ oc:ienti■t and may c:aUN • delay in
■pproval.
Pl- UM the C\ln"ellt version of tha form. To ■cceaa: on a blank WordParfect ■crMD, preaa Shift FlO, type
G:\FORMS\AUPRENEW.FO and preaa enter.
57243

Ronald J. Shebuski

7243

,,_._ 3

209

•��AS. LS. ttl.M-. ii a eipinmal c..._. le lM �
a1w.,,....iu. u.. ....w.....w-&Mt '- �......,.;.. •
.u•i.s.

Previous AUP Authorization Code (10 digits) and Log # (3 digits): AUP# 284-01-4-N320; Log# 547
Cate gory of procedure on authorized AUP: III

..,,_...-.ta.a,,.,• Ca...-,y n ..,...._. ud .__. ll&U-11

N-.: &aw ll/U(1M1U.....) lf..- wmaa a.rw •

.__. ....Tb&.,..

a C..Mtf'Orr v up,ari,un.

Animal Species: Porcine

Stock or Strain Name: Domestic Feeder Pigs and/or Yucatan Minipigs
Approximate number of animals to be used per year:
150
Anticipated location of
research or testing
procedure:

Bldg(s): 209

Fir: 3

Rm(s): 325A.325,324
3 J.. J./, I

For reporting purposes to AAALAC, for company a=editation, please provide a short (four words or less
description of the procedure (e.g., cardiac reperfusion, antibody production • Freunds adjuvant, infectious
disease):
Angioplasty-induced arterial restenosis
List any changes/additions to anesthetics, analgesics, or other treatments.
None

List any other changes in the protocol.
The procedure described for the '"Balloon angioplasty procedure·• and :!:e .. Chronic intr:i.venous
....... ... - .... : .. _ __ ,. .. ..: ••• ,.• ..::·• .; \C',.....:� � :.., •._;0..1': !_ ·_1' r:----: ·_1-..;'.! -��:1::-: ·'.":'! �;1:::.e.
.:1
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INTERNAL USE ONLY
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RENEWAL OF ANIMAL USE PROTOCOL CAUP) FORM

70-W.-212111

Page 2

O:\POIIM:s\AUPUJ<ff.PO

The rollowinr procedural addendum may be performed as time permits in 1995:
Addendum:. Effect or Swine Pox Vu:u, Infection on Neointimal Hyperplasia in Pigs

w

Baclqround: Dr. Karim Esaani (Western Michipn University)
been investiptinr the production or
anti-inOarnrnattiry proteins by pox viruses, sorne or which were found to inhibit intimal hyperplasia
induced by balloon an(iopla.sty of rabbit femoral arteries (G. McFadden et al., 10th International
Conference on Pomruses and Iridoviruses, April 30-May 5, 1994). Under Dr. Essani's ruidance, we will
investigate the potential anti-restenotic effect of swine pox virus infection in our porcine balloon
overinflation model of coronary artery restenosis.
Infection protocol:
1. Swine pox virus (10' po x forming units or pfu) will be injected intravenously in chronically cannulated
domestic feeder pip.
2. Seven days later, antibody titers in serum will be measured to confirm swine-pox infection.

pigs

3. Once infected,
will underro the standard balloon an(ioplasty procedure, with resultant vascular
injury responses quantitated as previously described.
4. Stringent methods will be used to keep the swine pox infection localize the infected pigs to one recovery
room; i.e. use of boots and coveralls that stay in the infected area; use of disinfectant shoe-trays.
Desaibe the alternatives considered during the past year to the procedures that may cause more than
momentary or slight pain or distress to the animals, including methods and sources used to
determine that alternatives were not available (e.g., The Animal Welfare Information Center).
As described in the 1994 AUP form, we feel that all necessary procedures that cause more than
momentary pain or distress are accompanied by adequate use uf anesthesia /analgesia. No alternative
methods were uncovered in reviewing current literature on pig models of restenosis (Corporate Technical
Library Medlars II Literature Review ofRestenosis Articles).
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Pleue indicate below information on poet-operative anal(esics and restraint, it appropriate. Please check
the Ion, form for required information (G:\FORMS\AUP.FO).
1. For our CateeorY III AUP, here ia a 1umm.ary of the eedatives, analresic or anesthetic of choice:

Drur
Dose
wt.)

<e.c� •�r body

Ketamine
(Anesthetic)

Midazolam
(Induction Agent)

Torbugesic
(Analgesic)

25 mr/q + 20-30
_

0.6 mrlq + 0.3-0.4

0.05-0.1 mg/kg

supplemental

supplemental

mlf'ka:fhr

Route and method of intra-muscular,
adminittratlon
bolus injection

mi/kg/hr

intra-muscular,
bolus injection

intra-muscular, bolus
injection

2. Un.anesthetized animals will not be physically restrained under this AUP.
3. Pain will be monitored durinir the auriical procedures by monitorinir reflex responses in the animals
(tail twitch upon needle prick to hindquarters/ limb withdrawal or movement upon hoof squeeze} every 30,o minutes. Upon recovery such abnormal behavior as.lethargy, failure to eat, or extreme agitation will be
used
an indication of moderate to severe pain. Animal behavior will thus be monitored daily during the
recovery period. Pip experienc:inir post-operative pain will be administered Torbugesic as outlined above.

as

4. Euthanasia is a planned event at the end of our study and will be achieved via i.v. injections of sodium
pentobarbital (Socumb, dosage � 50 mg/kg). If coronary balloon angioplasty complications occur that would
require major thoracic •urKery to repair, the animal will be euthanized rather than introduce more
complicated and extensive procedures to the protocol Additionally, any.recovery animals experiencing
behavioral signs of pain that prevent it from eating and drinking and which cannot be abated, with either
analgesic or antibiotic therapy, will also be euthanized prompUy.

In signing this renewal you acknowledge that the concerns listed under "Responsible Scientist's and
Management's Verification• (see G:\FORMS\AUP.FO) have been appropriately considered.
DATI

DATS

e:rten.sion 5-7577 or 5-7238

Appendix B
Protocol Clearance From the Institutional Animal
Care and Use Committee (IACUC),
Western Michigan University
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College of Ans and Soences
Department ol Bi<llc>l1(:al Sciences
Laborato,y ol Vorolog/

Kalamazoo, Md1igan 49008-3899
TeleOhone: 616 387-5636
FAX:
616 387-2849

E-ma,1:

BIOL_RESOgw.wmoch.edU

WESTERN MICHIGAN UNIVERSl1Y

January 27, 1998

TO WHOM IT MAY CONCERN
This is to certify that the animal protocols used in this study were appro\'ed by the IACUC in this univemty
(95-08--0 I for monoclonal antibodies) and the animal use comminec at the Pharmacia and Upjohn
Laboratories ( AUP # 28+01-5-N320: log# 1995�16 for swine studies).

Sincerely,

�<f,�

Karim Essani. Ph.D.
Associate Professor

�

�Ph.D.
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